Sonic Healthcare : Change of Director's Interest NoticeOpens in a new Window

Appendix 3Y

Change of Director's Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director's Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity

ABN

SONIC HEALTHCARE LIMITED 24 004 196 909

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Kathryn (Kate) Dianne Spargo
Date of last notice	28 August 2020

Part 1 - Change of director's relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of "notifiable interest of a director" should be disclosed in this part.

Direct or indirect interest	Direct and Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Fully paid ordinary shares in Sonic Healthcare Limited held via Spargo Super Pty Ltd Spargo Super Fund A/C
Date of change	1 March 2021
No. of securities held prior to change	Direct 3,000 fully paid ordinary shares in Sonic Healthcare Limited Indirect 19,000 fully paid ordinary shares in Sonic Healthcare Limited
Class	Fully paid ordinary Healthcare LimitedsharesinSonic
Number acquired	1,000 fully paid ordinary shares in Sonic Healthcare Limited
Number disposed	Nil
Value/Consideration Note: If consideration is non‐cash, provide details and estimated valuation	$31.679720 per share

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y

Change of Director's Interest Notice

No. of securities held after change	Direct 3,000 fully paid ordinary shares in Sonic Healthcare Limited Indirect 20,000 fully paid ordinary shares in Sonic Healthcare Limited
Nature of change Example: on‐market trade, off‐market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy‐back	On-market purchase

Part 2 - Change of director's interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of "notifiable interest of a director" should be disclosed in this part.

Detail of contract

Nature of interest

Name of registered holder (if issued securities)

Date of change

No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed

Interest acquired

Interest disposed

Value/Consideration Note: If consideration is non‐cash, provide details and an estimated valuation

Interest after change

Part 3 - +Closed period

+ See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y

Change of Director's Interest Notice

Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?

+ See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3